NBTX

26.5002.98%
AG

Anne-Marie Graffin

Independent Vice Chairwoman of the Supervisory Board

Ms. Anne-Marie Graffin serves as lead Independent Director at Sartorius Stedim Biotech S.A.Since January 2024. She has been a Managing Director of SMAG Consulting SARL since September 2011. Ms. Graffin served as Executive Director Business Management and Vice-President for Europe at Sanofi Pasteur MSD until 2010. She served as France Products Manager of International Distillers and Vinters, from 1984 to 1987; adhesive Marketing Manager of URGO Laboratories from 1988 to 1990; Head of International Marketing Group of RoC S.A (Johnson & Johnson) from 1991 to 1995; France Products Manager Adults Vaccines of Sanofi Pasteur MSD from 1998 to 2000; Head of range then Europe Adults Vaccines Marketing Director of Sanofi Pasteur from 2001 to 2005; Executive Manager Business Management of Sanofi Pasteur MSD from 2006 to 2008; Vice President Business Management of Sanofi Pasteur MSD from 2009 to 2010. Prior to that, she served in a variety of positions, most recently as a Vice President, at Sanofi Pasteur MSD, a European vaccine company, from 1998 to 2011. Ms. Graffin joined Sanofi Pasteur MSD in 1998. After a varied career of over 20 years in the pharmaceutical industry, Ms. Graffin has both expertise in developing market access strategies and in driving biotechnology companies' growth. She began her pharmaceutical career in The Group Fournier (URGO Soin et Santé) and Johnson & Johnson (RoC SA). She has been a consultant to the pharmaceutical industry since 2011 developing many initiatives within the innovation and startups fields, connecting biotech and medtech startups with major EU venture capital firms and investors. Before then, she worked for five years at ROC as international brand manager. Then, she worked for years at Sanofi Pasteur MSD, where she served as Director of Marketing, Adult Vaccines and Europe. She is a Member of the Board of Directors at M2Care. Ms. Graffin served at Jérôme SNOLLAERTS in November 2013. She is an expert and independent Director for industrial pharmaceutical companies and biotechnology firms. She had been a Member of the Supervisory Board at Valneva SE (Nantes, FR – Vienna, AT) since March 7, 2013 until December 20, 2023 and served as Chairman of the Board since December 20, 2023 until June 25, 2026 and is its Vice Chairman of the Board since June 25, 2026. She had been Non-Executive Independent Director of Sartorius Stedim Biotech S.A. (Aubagne, FR – Goëttingen, Ger) since April 7, 2015 to January 2023. She has experience in life sciences and pharmaceutical companies. She has been an Independent Member of the Supervisory Board at Nanobiotix SA since December 18, 2013 and served as its Vice Chairman of Supervisory Board since July 2017 until 2025 and serves as its Vice Chairwoman of the Supervisory Board. She served as Executive Director at Sanofi Pasteur MSD. She has been Member of the Board of Directors of Themis Bioscience GmBH from July 2012 to December 2014; Portugal Sanofi Pasteur MSD from March 2008 to December 2010; Spain Sanofi Pasteur MSD from March 2009 to December 2010; UK Sanofi Pasteur MSD from March 2009 to December 2010; Ireland Sanofi Pasteur MSD from March 2009 to December 2010. She served as Chief Executive Officer of the BigBooster Acceleration Program, an international non-profit acceleration program for startups, from 2011 to May 2017. Ms. Graffin received her MBA from ESSEC Business School Paris.

Positions